Brief: Cosmo Bio says Toshiaki Kasamatsu to resign from chairman
Table: Cosmo Bio -2016 group results
Table: Cosmo Bio -2016 div forecast
Table: Cosmo Bio -9-MTH group results
Table: Cosmo Bio -6-MTH group results
Table: Cosmo Bio -6-MTH group results
2016 6-month group forecast
Table: Cosmo Bio -2016 group forecast
Brief: Cosmo: successful outcome of phase III clinical trial for Rifamycin SV MMX
Table: Cosmo Bio -Q1 group results
Table: Cosmo Bio -2015 group results
Table: Cosmo Bio -2015 group forecast
Table: Cosmo Bio -2015 div forecast
Table: Cosmo Bio -9-MTH group results